Background
This disclosure is in continuation of the company's earlier intimation dated 20th August, 2026 (No: IGL/SE/2026-27/45) regarding receipt of the certified true copy of the order from the Hon'ble National Company Law Tribunal, Allahabad Bench, Prayagraj sanctioning the Scheme of Arrangement. The scheme involves India Glycols Limited (Demerged Company), Ennature Bio Pharma Limited (Resulting Company 1/EBL), and IGL Spirits Limited (Resulting Company 2/IGSL) and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.
Board Resolution
The Board of Directors of India Glycols Limited passed a resolution by circulation on 21st August, 2026, fixing:
- Effective Date: Tuesday, 1st September, 2026 - the date on which the certified true copy of the NCLT order sanctioning the Scheme will be filed by the Demerged Company and each of the Resulting Companies with the Registrar of Companies.
- Record Date: Wednesday, 2nd September, 2026 - fixed in consultation with both Resulting Company 1 (Ennature Bio Pharma Limited) and Resulting Company 2 (IGL Spirits Limited) for determining shareholders eligible for allotment of shares.
Share Allotment Details
The share allotment will occur in the following manner:
- Resulting Company 1 (Ennature Bio Pharma Limited): 1 Equity Share of face value INR 5 each will be issued to shareholders of Demerged Company holding 3 Equity Shares of INR 5 each.
- Resulting Company 2 (IGL Spirits Limited): 1 Equity Share of face value INR 5 each will be issued to shareholders of Demerged Company holding 1 Equity Share of INR 5 each.
Listing Arrangements
The equity shares to be allotted by each of the Resulting Companies pursuant to the Share Entitlement Ratio will be listed on the National Stock Exchange of India Limited and BSE Limited, subject to applicable regulations and necessary regulatory approvals.